3.2. atRA Reduces Viability and Stem Cell Related Properties in LCs from Flt3-ITD/Npm1c-Driven AML, but Experimental Expression of Evi1 Counteracts These Effects. The gene discussed is MECOM; the disease is acute myeloid leukemia.